- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma - Abstract
November 22, 2011
Partial elective nephrectomy - Abstract
November 21, 2011
Nursing considerations with pazopanib therapy: Focus on metastatic renal cell carcinoma - Abstract
November 18, 2011
Vaccines for colorectal cancer and renal cell carcinoma - Abstract
November 18, 2011
Systemic treatment of renal cell carcinoma - recent update - Abstract
November 18, 2011
Second-line therapy for refractory renal-cell carcinoma - Abstract
November 17, 2011
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: Results from a population based cohort - Abstract
November 16, 2011
Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma - Abstract
November 16, 2011
Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes - Abstract
November 16, 2011
Lymph node dissection in renal cell carcinoma - Abstract
November 15, 2011
Evaluation of renal masses with contrast-enhanced ultrasound: Initial experience - Abstract
November 15, 2011
Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma - Abstract
November 15, 2011
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: The role of CXCL cytokines - Abstract
November 14, 2011
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy - Abstract
November 14, 2011